Simon E. Ward

2.4k total citations
67 papers, 1.6k citations indexed

About

Simon E. Ward is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Simon E. Ward has authored 67 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 17 papers in Organic Chemistry and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in Simon E. Ward's work include Receptor Mechanisms and Signaling (9 papers), Neuroscience and Neuropharmacology Research (8 papers) and Cancer therapeutics and mechanisms (7 papers). Simon E. Ward is often cited by papers focused on Receptor Mechanisms and Signaling (9 papers), Neuroscience and Neuropharmacology Research (8 papers) and Cancer therapeutics and mechanisms (7 papers). Simon E. Ward collaborates with scholars based in United Kingdom, United States and Brazil. Simon E. Ward's co-authors include Laurence H. Pearl, Frances M. G. Pearl, Amanda C. Schierz, Bissan Al‐Lazikani, Paul Beswick, Mark H Harries, Nigel S. Simpkins, Vincent Rodeschini, B.D. Bax and John Atack and has published in prestigious journals such as Nucleic Acids Research, Nature reviews. Cancer and Cancer Research.

In The Last Decade

Simon E. Ward

66 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon E. Ward United Kingdom 22 933 421 359 218 142 67 1.6k
Robert L. Hudkins United States 24 1.3k 1.4× 650 1.5× 364 1.0× 309 1.4× 214 1.5× 89 2.2k
Carina Shayo Argentina 22 750 0.8× 535 1.3× 268 0.7× 164 0.8× 232 1.6× 56 1.7k
Peter Chase United States 24 1.2k 1.3× 224 0.5× 221 0.6× 214 1.0× 62 0.4× 68 2.0k
Russell Dahl United States 34 1.7k 1.8× 481 1.1× 351 1.0× 442 2.0× 102 0.7× 71 2.8k
Yoko Nagumo Japan 23 615 0.7× 358 0.9× 140 0.4× 94 0.4× 134 0.9× 51 1.2k
Chenbo Zeng United States 29 1.8k 1.9× 292 0.7× 287 0.8× 417 1.9× 104 0.7× 40 2.4k
Anna C. Maroney United States 24 1.8k 1.9× 219 0.5× 465 1.3× 556 2.6× 167 1.2× 31 2.6k
B. V. L. POTTER United Kingdom 35 2.4k 2.6× 664 1.6× 291 0.8× 358 1.6× 172 1.2× 97 3.6k
Guangrong Zheng United States 30 2.3k 2.5× 402 1.0× 663 1.8× 435 2.0× 182 1.3× 156 3.4k

Countries citing papers authored by Simon E. Ward

Since Specialization
Citations

This map shows the geographic impact of Simon E. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon E. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon E. Ward more than expected).

Fields of papers citing papers by Simon E. Ward

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon E. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon E. Ward. The network helps show where Simon E. Ward may publish in the future.

Co-authorship network of co-authors of Simon E. Ward

This figure shows the co-authorship network connecting the top 25 collaborators of Simon E. Ward. A scholar is included among the top collaborators of Simon E. Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon E. Ward. Simon E. Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nicholls, Robert A., Anna J. Warren, Simon E. Ward, et al.. (2024). How Do Gepotidacin and Zoliflodacin Stabilize DNA Cleavage Complexes with Bacterial Type IIA Topoisomerases? 1. Experimental Definition of Metal Binding Sites. International Journal of Molecular Sciences. 25(21). 11688–11688. 1 indexed citations
2.
Nicholls, Robert A., et al.. (2024). How Do Gepotidacin and Zoliflodacin Stabilize DNA-Cleavage Complexes with Bacterial Type IIA Topoisomerases? 2. A Single Moving Metal Mechanism. International Journal of Molecular Sciences. 26(1). 33–33. 1 indexed citations
3.
Sorrell, F.J., James M. Bennett, Oleg Fedorov, et al.. (2024). Imidazo[1,2-b]pyridazines as inhibitors of DYRK kinases. European Journal of Medicinal Chemistry. 269. 116292–116292. 4 indexed citations
4.
Galuska, Sebastian P., et al.. (2023). Cancer-specific glycosylation of CD13 impacts its detection and activity in preclinical cancer tissues. iScience. 26(11). 108219–108219. 4 indexed citations
5.
Ward, Simon E., et al.. (2023). Central Nervous System Targeted Protein Degraders. Biomolecules. 13(8). 1164–1164. 14 indexed citations
6.
Elvers, Karen T, S. Mark Roe, Simon E. Ward, et al.. (2022). Tyrosine 121 moves revealing a ligandable pocket that couples catalysis to ATP-binding in serine racemase. Communications Biology. 5(1). 346–346. 5 indexed citations
7.
Kenyon, Emma, Nerissa K. Kirkwood, Richard J. Goodyear, et al.. (2021). Identification of a series of hair-cell MET channel blockers that protect against aminoglycoside-induced ototoxicity. JCI Insight. 6(7). 23 indexed citations
8.
Scott, Fiona L., M. Angela, Lewis E. Pennicott, et al.. (2020). Development of 2-(4-pyridyl)-benzimidazoles as PKN2 chemical tools to probe cancer. Bioorganic & Medicinal Chemistry Letters. 30(8). 127040–127040. 16 indexed citations
9.
Ward, Simon E., Mark H Harries, Laura Aldegheri, et al.. (2019). Pharmacological characterisation of MDI-222, a novel AMPA receptor positive allosteric modulator with an improved safety profile. Journal of Psychopharmacology. 34(1). 93–102. 14 indexed citations
10.
Ward, Simon E., et al.. (2018). Metal-free selective mono-halodecarboxylation of heteroarenes under mild conditions. Royal Society Open Science. 5(6). 180333–180333. 8 indexed citations
11.
Askwith, Trevor, John Atack, Paul Beswick, et al.. (2017). African trypanosomiasis: Synthesis & SAR enabling novel drug discovery of ubiquinol mimics for trypanosome alternative oxidase. European Journal of Medicinal Chemistry. 141. 676–689. 15 indexed citations
12.
Meisenberg, Cornelia, Mohamed E. Ashour, Chunyan Liao, et al.. (2016). Epigenetic changes in histone acetylation underpin resistance to the topoisomerase I inhibitor irinotecan. Nucleic Acids Research. 45(3). gkw1026–gkw1026. 46 indexed citations
13.
Pearl, Laurence H., Amanda C. Schierz, Simon E. Ward, Bissan Al‐Lazikani, & Frances M. G. Pearl. (2015). Therapeutic opportunities within the DNA damage response. Nature reviews. Cancer. 15(3). 166–180. 391 indexed citations
14.
Walker, Sarah, Cornelia Meisenberg, Trevor Askwith, et al.. (2014). Development of an oligonucleotide-based fluorescence assay for the identification of tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors. Analytical Biochemistry. 454. 17–22. 13 indexed citations
15.
Ward, Simon E. & Mark H Harries. (2010). Recent Advances in the Discovery of Selective AMPA Receptor Positive Allosteric Modulators. Current Medicinal Chemistry. 17(30). 3503–3513. 19 indexed citations
16.
Alderton, W., Eric Karran, & Simon E. Ward. (2009). Current and future perspectives in psychiatric drug discovery. Drug News & Perspectives. 22(6). 360–360. 6 indexed citations
17.
Atton, Chris, Alistair McCleery, Hayes Mawindi Mabweazara, & Simon E. Ward. (2008). Creative Futures: Building the Creative Economy through Universities.. Edinburgh Napier Research Repository (Edinburgh Napier University). 3 indexed citations
18.
Ward, Simon E., Peter Eddershaw, Laurie Gordon, et al.. (2008). Studies on a series of potent, orally bioavailable, 5-HT1 receptor ligands—Part II. Bioorganic & Medicinal Chemistry Letters. 19(2). 428–432. 7 indexed citations
19.
Ward, Simon E., Peter J. Lovell, Claire M. Scott, et al.. (2007). Studies on a series of potent, orally bioavailable, 5-HT1 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 17(18). 5214–5217. 6 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert L. Hudkins Breakdown of academic impact, for papers by Carina Shayo Breakdown of academic impact, for papers by Peter Chase Breakdown of academic impact, for papers by Russell Dahl Breakdown of academic impact, for papers by Yoko Nagumo Breakdown of academic impact, for papers by Chenbo Zeng Breakdown of academic impact, for papers by Anna C. Maroney Breakdown of academic impact, for papers by B. V. L. POTTER Breakdown of academic impact, for papers by Guangrong Zheng
Rankless by CCL
2026